Assertio Logo.jpg
Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
March 11, 2024 16:01 ET | Assertio Holdings, Inc.
Fourth Quarter Net Product Sales $32.5 Million, Cash Flow from Operations of $5.7 Million 2024 Full Year Outlook for Net Product Sales of $110 to $125 Million,...
Assertio Logo.jpg
Assertio Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
February 29, 2024 16:05 ET | Assertio Holdings, Inc.
LAKE FOREST, Ill., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company that acquires, commercializes and...
Assertio Logo.jpg
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
January 05, 2024 18:56 ET | Assertio Holdings, Inc.
LAKE FOREST, Ill., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company that acquires, commercializes and...
Assertio Logo.jpg
Assertio Holdings, Inc. Announces Leadership Transition
January 03, 2024 08:59 ET | Assertio Holdings, Inc.
Dan Peisert Stepping Down as CEO Board member Heather Mason Appointed Interim CEO LAKE FOREST, Ill., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the...
Assertio Logo.jpg
Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors
November 14, 2023 08:00 ET | Assertio Holdings, Inc.
LAKE FOREST, Ill., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company that acquires, commercializes and...
Assertio Logo.jpg
Assertio Reports Third Quarter 2023 Financial Results
November 08, 2023 16:01 ET | Assertio Holdings, Inc.
Closed Spectrum Acquisition on July 31, 2023, which diversifies and extends portfolio duration Cash balance at September 30, 2023 of $76.9 million Announces Management Updates LAKE FOREST, Ill., Nov....
Assertio Logo.jpg
Assertio Holdings, Inc. to Release Third Quarter 2023 Financial Results on November 8, 2023
November 02, 2023 12:06 ET | Assertio Holdings, Inc.
LAKE FOREST, Ill., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Logo.jpg
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 06, 2023 16:30 ET | Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Logo.jpg
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
August 25, 2023 16:05 ET | Assertio Holdings, Inc.
LAKE FOREST, Ill., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Logo.jpg
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
August 08, 2023 16:45 ET | Assertio Holdings, Inc.
LAKE FOREST, Ill., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to...